✦ LIBER ✦

Apolipoprotein E gene in Parkinson's disease with or without dementia

✍ Scribed by Hiroyuki Arai; Taro Muramatsu; Susumu Higuchi; Hidetada Sasaki; JohnQ. Trojanowski

Book ID: 118556779
Publisher: The Lancet
Year: 1994
Tongue: English
Weight: 170 KB
Volume: 344
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(94)92862-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Apolipoprotein E genotypes in Parkinson'

Apolipoprotein E genotypes in Parkinson's disease with and without dementia

✍ William C. Koller; Sander L. Glatt; Jean P. Hubble; Anthony Paolo; Alexander I. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB 👁 2 views

Apolipoprotein E gene in diffuse Lewy bo

Apolipoprotein E gene in diffuse Lewy body disease with or without co-existing Alzheimer's disease

✍ Hiroyuki Arai; Susumu Higuchi; Taro Muramatsu; Takeshi Iwatsubo; Hidetada Sasaki 📂 Article 📅 1994 🏛 The Lancet 🌐 English ⚖ 147 KB

Apolipoprotein E genes in Lewy body and

Apolipoprotein E genes in Lewy body and Parkinson's disease

✍ R. Benjamin; A. Leake; J.A. Edwardson; I.G. McKeith; P.G. Ince; R.H. Perry; C.M. 📂 Article 📅 1994 🏛 The Lancet 🌐 English ⚖ 153 KB

The apolipoprotein E gene in Binswanger'

The apolipoprotein E gene in Binswanger's disease and vascular dementia

✍ Susumu Higuchi; Hiroyuki Arai; Takuma Nakagawa; Taro Muramatsu; Hidetada Sasaki; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB

Release signs in Parkinson's disease wit

Release signs in Parkinson's disease with and without dementia

✍ A. Marterer-Travniczek; W. Danielczyk; F. Müller; M. Simanyi; P. Fischer 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 371 KB

Cognitive impairment in Parkinson's dise

Cognitive impairment in Parkinson's disease without dementia

✍ Javier Rodríguez-Ferreiro; Fernando Cuetos; Elena Herrera; Manuel Menéndez; René 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract Some degree of cognitive impairment appears frequently in Parkinson's disease (PD) patients, even at the onset of the disease. However, due to the heterogeneity of the patients and the lack of standardized assessment batteries, it remains unclear which capacities are primarily affected